7.17

0.83% -0.06

After Hours: 6.87 -0.30 -4.18%

Bioventus Inc (BVS)

Overview News Price History Option Chain Financials Discussions Forecast

Bioventus Inc stock is traded at $7.17, with a volume of 288.78K. It is down -0.83% in the last 24 hours and down -2.71% over the past month. Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Previous Close:

$7.23

Open:

$7.3

24h Volume:

288.78K

Relative Volume:

0.65

Market Cap:

$479.62M

Revenue:

$555.06M

Net Income/Loss:

$-39.48M

P/E Ratio:

-11.95

EPS:

-0.6

Net Cash Flow:

$29.05M

1W Performance:

-0.55%

1M Performance:

-2.71%

6M Performance:

-25.39%

1Y Performance:

-35.81%

1-Day Range:

$7.15

$7.38

1-Week Range:

$6.98

$7.41

52-Week Range:

$5.81

$14.38

Bioventus Inc Stock (BVS) Company Profile

Name

Bioventus Inc

Sector

Healthcare (1153)

Industry

Medical Devices (147)

Phone

(919) 474-6700

Address

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Employee

950

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

BVS's Discussions on Twitter

Compare BVS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BVS Bioventus Inc	7.17	483.63M	555.06M	-39.48M	29.05M	-0.60
ABT Abbott Laboratories	131.33	232.75B	43.11B	13.94B	6.78B	7.98
BSX Boston Scientific Corp	99.87	152.19B	18.49B	2.50B	3.49B	1.68
SYK Stryker Corp	377.11	146.55B	23.82B	2.92B	4.02B	7.55
MDT Medtronic Plc	93.43	120.61B	34.20B	4.69B	5.30B	3.63
EW Edwards Lifesciences Corp	76.05	45.54B	5.69B	1.41B	577.90M	6.95

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Mar-15-22	Initiated	Craig Hallum	Buy
Nov-15-21	Resumed	Morgan Stanley	Overweight
Nov-10-21	Resumed	JP Morgan	Overweight
Jul-01-21	Downgrade	Goldman	Buy → Neutral
Mar-08-21	Initiated	Canaccord Genuity	Buy
Mar-08-21	Initiated	Goldman	Buy
Mar-08-21	Initiated	JP Morgan	Overweight
Mar-08-21	Initiated	Morgan Stanley	Overweight

View All

Bioventus Inc Stock (BVS) Latest News

09:40 AM

Aug Retail: Will Bioventus Inc benefit from current market trends2025 Growth vs Value & Safe Entry Trade Signal Reports - خودرو بانک

09:40 AM

08:52 AM

Sentiment Recap: How is Kirkland s Inc. managing supply chain issuesCEO Change & Weekly Setup with High ROI Potential - خودرو بانک

08:52 AM

08:23 AM

Will a bounce in Bioventus Inc. offer an exit2025 Technical Overview & Low Drawdown Investment Strategies - newser.com

08:23 AM

02:04 AM

Forecasting Bioventus Inc. price range with options dataMarket Activity Report & Stepwise Entry and Exit Trade Signals - newser.com

02:04 AM

Sep 14, 2025

Price momentum metrics for Bioventus Inc. explainedTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Sep 14, 2025

When is the best time to exit Bioventus Inc.Market Growth Review & Weekly Watchlist for Hot Stocks - newser.com

Sep 14, 2025

Jacobs Levy Equity Management Inc. Decreases Holdings in Bioventus Inc. $BVS - MarketBeat

Sep 14, 2025

Sep 13, 2025

Chart based exit strategy for Bioventus Inc.Market Growth Review & Risk Controlled Swing Alerts - newser.com

Sep 13, 2025

What Fibonacci levels say about Bioventus Inc. reboundPortfolio Return Report & Smart Money Movement Alerts - newser.com

Sep 13, 2025

Cubist Systematic Strategies LLC Acquires 116,418 Shares of Bioventus Inc. $BVS - MarketBeat

Sep 13, 2025

Sep 11, 2025

TR | OpenAI4o Maintains Bioventus(BVS.US) With Hold Rating, Raises Target Price to $8 - 富途牛牛

Sep 11, 2025

Sep 10, 2025

Peripheral nerve stimulator Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes, DelveInsight | B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwav - Barchart.com

Sep 10, 2025

Sep 08, 2025

Investors Hope for Bounce in Bioventus Inc. After SelloffCPI Data & Stepwise Trade Signal Guides - beatles.ru

Sep 08, 2025

Will Bioventus Inc. Reverse From Oversold ConditionsGDP Growth & Free Risk Controlled Daily Trade Plans - beatles.ru

Sep 08, 2025

Published on: 2025-09-08 13:50:02 - beatles.ru

Sep 08, 2025

Sep 07, 2025

Will Bioventus Inc. benefit from seasonalityJuly 2025 Weekly Recap & AI Enhanced Execution Alerts - beatles.ru

Sep 07, 2025

Is now the right time to enter Bioventus Inc.2025 Fundamental Recap & Daily Chart Pattern Signal Reports - beatles.ru

Sep 07, 2025

Bioventus enters into a new $400M credit agreement, lowering interest expenses - MSN

Sep 07, 2025

Sep 06, 2025

What recovery options are there for Bioventus Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser

Sep 06, 2025